EUVIMEDEUVIMED entdecken
Open Access

Usefulness of business intelligence to guide antimicrobial treatment decision in infections by infrequent microorganism such as Bordetella bronchiseptica

Ángel Rodríguez-Villodres iD, María Valentina Hoffmann-Álvarez, Pedro Camacho-Martínez iD, José Antonio Lepe iD

Revista Española de Quimioterapia · 2025

DOI: 10.37201/req/125.2024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Española de Quimioterapia, 2025. Verfasst von Ángel Rodríguez-Villodres und 3 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Rocío, Seville, Spain. Hauptthemen laut MEDLINE: Bordetella bronchiseptica, Bordetella Infections, Anti-Bacterial Agents. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Human infections by Bordetella bronchiseptica are increasing in recent years. However, due to the lack of clinical susceptibility/resistance breakpoints, antimicrobial treatment is complex. Business Intelligence (BI) is a tool that allows to record and analyze large amounts of data in a very short time. The aim of this study was to analyze a cohort of patients with B. bronchiseptica infections focusing on how BI can help guide empirical antimicrobial therapy Demographic, clinical, and microbiological data about B. bronchiseptica infections were recovered. Then, MIC50/90 of several antibiotics was automatically calculated through the BI. Thirteen B. bronchiseptica infections were identified. The lowest MICs90 were for carbapenem, aminoglycoside, fluoroquinolones, and tetracyclines. The EUCAST PK-PD (non-species related) breakpoints showed that only piperacillin/tazobactam, imipenem and meropenem would be appropriate treatments to use empirically. In conclusion, BI systems have great potential to optimize the empirical antibiotic treatment in these types of infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bordetella bronchisepticaBordetella InfectionsAnti-Bacterial AgentsHumansMicrobial Sensitivity TestsMaleMiddle AgedFemaleAgedAdultYoung AdultAged, 80 and over

Stichwörter der Autor:innen

Antimicrobial treatmentBordetella bronchisepticaBusiness intelligenceRespiratory tract infection

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Clinical Unit of Infectious Diseases, Microbiology and Preventive Medicine, University Hospital Virgen del Rocío, Seville, Spain.
  • Institute of Biomedicine of Seville, University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain. anrovi1797@gmail.com.
  • Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Madrid, Spain.
  • Department of Microbiology, University of Seville, Seville, Spain.

ORCID-Profile: Ángel Rodríguez-Villodres, Pedro Camacho-Martínez, José Antonio Lepe

Zitieren

APA

Rodríguez-Villodres, Á., Hoffmann-Álvarez, M. V., Camacho-Martínez, P., & Lepe, J. A. (2025). Usefulness of business intelligence to guide antimicrobial treatment decision in infections by infrequent microorganism such as Bordetella bronchiseptica. Revista Española de Quimioterapia. https://doi.org/10.37201/req/125.2024

Vancouver

Rodríguez-Villodres Á, Hoffmann-Álvarez MV, Camacho-Martínez P, Lepe JA. Usefulness of business intelligence to guide antimicrobial treatment decision in infections by infrequent microorganism such as Bordetella bronchiseptica. Revista Española de Quimioterapia. 2025. doi:10.37201/req/125.2024

BibTeX
@article{RodrguezVillodres2025,
  author = {Rodríguez-Villodres, Ángel and Hoffmann-Álvarez, María Valentina and Camacho-Martínez, Pedro and Lepe, José Antonio},
  title = {Usefulness of business intelligence to guide antimicrobial treatment decision in infections by infrequent microorganism such as Bordetella bronchiseptica},
  journal = {Revista Española de Quimioterapia},
  year = {2025},
  doi = {10.37201/req/125.2024}
}
Kostenlos starten →